Accium BioSciences, Inc. Takes $3 Million Series A Published: Jan 06, 2006 Accium BioSciences, a provider of bioanalytical services with a focus on early-stage drug development, has raised $3 million in a Series A round. Related links VentureReporter.net [Registration Required] This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news